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ABSTRACT 
 
Vivian Y. Wahaidi 
 
The Systemic Inflammatory Response to Dental Plaque 
 
Introduction: Bacteremia involving oral bacteria and the systemic inflammatory 
responses are mechanisms that could causally link oral and systemic diseases. Objective: 
To use an experimental gingivitis model (EGM) in 2 clinical studies to 1) examine the 
systemic inflammatory responses to dental plaque, and assess racial differences in these 
responses; 2) determine whether dental plaque accumulation causes bacteremia and 
subsequent systemic responses following toothbrushing. Additionally, a laboratory study 
was conducted to examine the interaction between circulating human neutrophils and 
Fusobacterium  nucleatum. Methods: For both clinical studies, healthy adults, aged 18-31 
years, were recruited. In the first study, black and white, males and females participated 
in a 21-day EGM; in the second study, white adults participated in a 7-day EGM. In both 
studies, subjects visited the clinic weekly for: 1) measurement of the plaque index (PI) 
and gingival index (GI); 2) collection of peripheral blood samples to evaluate systemic 
markers of inflammation. In the second study, to analyze bacteremic episodes during the 
experimental phase, peripheral blood samples were collected at baseline and at 0.5, 5, and 
30 minutes post-toothbrushing. In the laboratory study, interactions between F. 
nucleatum and circulating neutrophils were examined using a luminol-enhanced 
chemiluminescence assay. Results: During the experimental phases of both clinical 
studies, PI and GI increased (p<0.05) with a correlation between PI and GI ≥0.79. In the 
first study, dental plaque accumulation resulted in a systemic response that manifested as 
  vii 
changes (p<0.05) in the level of inflammatory markers, hematologic factors, markers of 
lipid metabolism, and markers of metabolic change. This systemic response differed 
between individuals of different gender and race. In the second study, bacteremic 
episodes and changes in hematologic factors were observed post-toothbrushing during the 
experimental phase. Activation of neutrophils with F. nucleatum, in the laboratory study, 
increased the levels of neutrophil chemiluminescence (p<0.05). Conclusions: Overall, the 
findings of these investigations may shed light on the mechanistic pathways by which 
oral infection may impose risk for systemic diseases and provide some evidence to 
support a possible causal association between oral and systemic diseases. The clinical 
significance of this in systemic inflammatory diseases requires further investigation. 
 
Michael J. Kowolik, B.D.S., Ph.D., Chair 
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